The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
An extent of resection threshold for newly diagnosed glioblastomas: Clinical article
Abstract
Object: The value of extent of resection (EOR) in improving survival in patients with glioblastoma multiforme (GBM) remains controversial. Specifically, it is unclear what proportion of contrast-enhancing tumor must be resected for a survival advantage and how much survival improves beyond this threshold. The authors attempt to define these values for the patient with newly diagnosed GBM in the modern neurosurgical era. Methods: The authors identified 500 consecutive newly diagnosed patients with supratentorial GBM treated at the University of California, San Francisco between 1997 and 2009. Clinical, radiographic, and outcome parameters were measured for each case, including MR imaging–based volumetric tumor analysis. Results: The patients had a median age of 60 years and presented with a median Karnofsky Performance Scale (KPS) score of 80. The mean clinical follow-up period was 15.3 months, and no patient was unaccounted for. All patients underwent resection followed by chemotherapy and radiation therapy. The median postoperative tumor volume was 2.3 cm 3, equating to a 96% EOR. The median overall survival was 12.2 months. Using Cox proportional hazards analysis, age, KPS score, and EOR were predictive of survival (p < 0.0001). A significant survival advantage was seen with as little as 78% EOR, and stepwise improvement in survival was evident even in the 95%–100% EOR range. A recursive partitioning analysis validated these findings and provided additional risk stratification parameters related to age, EOR, and tumor burden. Conclusions: For patients with newly diagnosed GBMs, aggressive EOR equates to improvement in overall survival, even at the highest levels of resection. Interestingly, subtotal resections as low as 78% also correspond to a survival benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Stummer, W., Pichlmeier, U., Meinel, T., Wiestler, O. D., Zanella, F., & Reulen, H.-J. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70665-9 · Cited by 3,423
Lacroix, M., Abi-Said, D., Fourney, D. R., Gokaslan, Z. L., Shi, W., DeMonte, F., Lang, F. F., McCutcheon, I. E., Hassenbusch, S. J., Holland, E., et al. (2001) · Journal of Neurosurgery · doi:10.3171/jns.2001.95.2.0190 · Cited by 3,091
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
Sanai, N., & Berger, M. S. (2008) · Neurosurgery · doi:10.1227/01.neu.0000318159.21731.cf · Cited by 1,328
Self-citationRole of extent of resection in the long-term outcome of low-grade hemispheric gliomas
Smith, J. S., Chang, E. F., Lamborn, K. R., Chang, S. M., Prados, M. D., Cha, S., Tihan, T., VandenBerg, S., McDermott, M. W., & Berger, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9337 · Cited by 1,283
Self-citationDangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
Altman, D. G., Lausen, B., Sauerbrei, W., & Schumacher, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.829 · Cited by 1,143
Stummer, W., Reulen, H.-J., Meinel, T., Pichlmeier, U., Schumacher, W., Tonn, J.-C., Rohde, V., Oppel, F., Turowski, B., Woiciechowsky, C., et al. (2008) · Neurosurgery · doi:10.1227/01.neu.0000317304.31579.17 · Cited by 1,035
Debulking or biopsy of malignant glioma in elderly people – a randomised study
Vuorinen, V., Hinkka, S., Färkkilä, M., & Jääskeläinen, J. (2003) · Acta Neurochirurgica · doi:10.1007/s00701-002-1030-6 · Cited by 370
Sanai, N., Polley, M.-Y., & Berger, M. S. (2010) · Journal of Neurosurgery · doi:10.3171/2009.6.jns0952 · Cited by 349
Self-citation
Cited by
Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168
Weller, M., Wick, W., Aldape, K., Brada, M., Berger, M., Pfister, S. M., Nishikawa, R., Rosenthal, M., Wen, P. Y., Stupp, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.17 · Cited by 1,124
Self-citationBrown, T. J., Brennan, M. C., Li, M., Church, E. W., Brandmeir, N. J., Rakszawski, K. L., Patel, A. S., Rizk, E. B., Suki, D., Sawaya, R., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1373 · Cited by 1,081
Impact of Intraoperative Stimulation Brain Mapping on Glioma Surgery Outcome: A Meta-Analysis
De Witt Hamer, P. C., Robles, S. G., Zwinderman, A. H., Duffau, H., & Berger, M. S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4818 · Cited by 1,044
Self-citationSenft, C., Bink, A., Franz, K., Vatter, H., Gasser, T., & Seifert, V. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70196-6 · Cited by 826
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
Wu, W., Klockow, J. L., Zhang, M., Lafortune, F., Chang, E., Jin, L., Wu, Y., & Daldrup-Link, H. E. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105780 · Cited by 805
Alexander, B. M., & Cloughesy, T. F. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.0119 · Cited by 788
Genetic and molecular epidemiology of adult diffuse glioma
Molinaro, A. M., Taylor, J. W., Wiencke, J. K., & Wrensch, M. R. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0220-2 · Cited by 709
Survival in glioblastoma: a review on the impact of treatment modalities
Delgado-López, P. D., & Corrales-García, E. M. (2016) · Clinical and Translational Oncology · doi:10.1007/s12094-016-1497-x · Cited by 659
Li, Y. M., Suki, D., Hess, K., & Sawaya, R. (2016) · Journal of Neurosurgery · doi:10.3171/2015.5.jns142087 · Cited by 646
Molinaro, A. M., Hervey-Jumper, S., Morshed, R. A., Young, J., Han, S. J., Chunduru, P., Zhang, Y., Phillips, J. J., Shai, A., Lafontaine, M., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2019.6143 · Cited by 631
Self-citationIntraoperative brain cancer detection with Raman spectroscopy in humans
Jermyn, M., Mok, K., Mercier, J., Desroches, J., Pichette, J., Saint-Arnaud, K., Bernstein, L., Guiot, M.-C., Petrecca, K., & Leblond, F. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa2384 · Cited by 618
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Jiang, T., Mao, Y., Ma, W., Mao, Q., You, Y., Yang, X., Jiang, C., Kang, C., Li, X., Chen, L., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.024 · Cited by 607
Current and future strategies for treatment of glioma
Bush, N. A. O., Chang, S. M., & Berger, M. S. (2017) · Neurosurgical Review · doi:10.1007/s10143-016-0709-8 · Cited by 577
Self-citationOrringer, D. A., Pandian, B., Niknafs, Y. S., Hollon, T. C., Boyle, J., Lewis, S., Garrard, M., Hervey-Jumper, S. L., Garton, H. J. L., Maher, C. O., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0027 · Cited by 568
Rapid, Label-Free Detection of Brain Tumors with Stimulated Raman Scattering Microscopy
Ji, M., Orringer, D. A., Freudiger, C. W., Ramkissoon, S., Liu, X., Lau, D., Golby, A. J., Norton, I., Hayashi, M., Agar, N. Y. R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005954 · Cited by 513
Overcoming therapeutic resistance in glioblastoma: the way forward
Osuka, S., & Van Meir, E. G. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89587 · Cited by 511
Chaichana, K. L., Jusue-Torres, I., Navarro-Ramirez, R., Raza, S. M., Pascual-Gallego, M., Ibrahim, A., Hernandez-Hermann, M., Gomez, L., Ye, X., Weingart, J. D., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not137 · Cited by 505
Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials
Ellingson, B. M., Wen, P. Y., & Cloughesy, T. F. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0507-6 · Cited by 476
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802997-8.00023-2 · Cited by 472
Maximizing safe resection of low- and high-grade glioma
Hervey-Jumper, S. L., & Berger, M. S. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2110-4 · Cited by 471
Self-citationAwake craniotomy to maximize glioma resection: methods and technical nuances over a 27-year period
Hervey-Jumper, S. L., Li, J., Lau, D., Molinaro, A. M., Perry, D. W., Meng, L., & Berger, M. S. (2015) · Journal of Neurosurgery · doi:10.3171/2014.10.jns141520 · Cited by 451
Self-citationGrabowski, M. M., Recinos, P. F., Nowacki, A. S., Schroeder, J. L., Angelov, L., Barnett, G. H., & Vogelbaum, M. A. (2014) · Journal of Neurosurgery · doi:10.3171/2014.7.jns132449 · Cited by 435
Impact of extent of resection for recurrent glioblastoma on overall survival: Clinical article
Bloch, O., Han, S. J., Cha, S., Sun, M. Z., Aghi, M. K., McDermott, M. W., Berger, M. S., & Parsa, A. T. (2012) · Journal of Neurosurgery · doi:10.3171/2012.9.jns12504 · Cited by 432
Self-citationClinical practice guidelines for the management of adult diffuse gliomas
Jiang, T., Nam, D.-H., Ram, Z., Poon, W.-S., Wang, J., Boldbaatar, D., Mao, Y., Ma, W., Mao, Q., You, Y., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.10.050 · Cited by 431
Karschnia, P., Young, J. S., Dono, A., Häni, L., Sciortino, T., Bruno, F., Juenger, S. T., Teske, N., Morshed, R. A., Haddad, A. F., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noac193 · Cited by 384
Self-citation5-ALA and FDA Approval for Glioma Surgery
Hadjipanayis, C. G., & Stummer, W. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03098-y · Cited by 338
Surgical oncology for gliomas: the state of the art
Sanai, N., & Berger, M. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.171 · Cited by 332
Self-citationHematogenous dissemination of glioblastoma multiforme
Müller, C., Holtschmidt, J., Auer, M., Heitzer, E., Lamszus, K., Schulte, A., Matschke, J., Langer-Freitag, S., Gasch, C., Stoupiec, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009095 · Cited by 328
Kut, C., Chaichana, K. L., Xi, J., Raza, S. M., Ye, X., McVeigh, E. R., Rodriguez, F. J., Quiñones-Hinojosa, A., & Li, X. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010611 · Cited by 323
Detection of human brain tumor infiltration with quantitative stimulated Raman scattering microscopy
Ji, M., Lewis, S., Camelo-Piragua, S., Ramkissoon, S. H., Snuderl, M., Venneti, S., Fisher-Hubbard, A., Garrard, M., Fu, D., Wang, A. C., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0195 · Cited by 320
Self-citationOrringer, D., Lau, D., Khatri, S., Zamora-Berridi, G. J., Zhang, K., Wu, C., Chaudhary, N., & Sagher, O. (2012) · Journal of Neurosurgery · doi:10.3171/2012.8.jns12234 · Cited by 317
Marko, N. F., Weil, R. J., Schroeder, J. L., Lang, F. F., Suki, D., & Sawaya, R. E. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.8886 · Cited by 315
Current trends in the surgical management and treatment of adult glioblastoma.
Young, R. M., Jamshidi, A. M., Davis, G., & Sherman, J. H. (2015) · PubMed · doi:10.3978/j.issn.2305-5839.2015.05.10 · Cited by 308
Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors
Eberlin, L. S., Norton, I., Orringer, D., Dunn, I. F., Liu, X., Ide, J. L., Jarmusch, A. K., Ligon, K. L., Jolesz, F. A., Golby, A. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215687110 · Cited by 288
Advances in Brain Tumor Surgery for Glioblastoma in Adults
Lara-Velazquez, M., Al-Kharboosh, R., Jeanneret, S., Vazquez-Ramos, C., Mahato, D., Tavanaiepour, D., Rahmathulla, G., & Quinones-Hinojosa, A. (2017) · Brain Sciences · doi:10.3390/brainsci7120166 · Cited by 285
McFaline-Figueroa, J. R., & Lee, E. Q. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.12.039 · Cited by 272
Ringel, F., Pape, H., Sabel, M., Krex, D., Bock, H. C., Misch, M., Weyerbrock, A., Westermaier, T., Senft, C., Schucht, P., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov145 · Cited by 267
Neuronavigation in the surgical management of brain tumors: current and future trends
Orringer, D. A., Golby, A., & Jolesz, F. (2012) · Expert Review of Medical Devices · doi:10.1586/erd.12.42 · Cited by 267
Oppenlander, M. E., Wolf, A. B., Snyder, L. A., Bina, R., Wilson, J. R., Coons, S. W., Ashby, L. S., Brachman, D., Nakaji, P., Porter, R. W., et al. (2014) · Journal of Neurosurgery · doi:10.3171/2013.12.jns13184 · Cited by 266
Self-citationIntraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery
Santagata, S., Eberlin, L. S., Norton, I., Calligaris, D., Feldman, D. R., Ide, J. L., Liu, X., Wiley, J. S., Vestal, M. L., Ramkissoon, S. H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404724111 · Cited by 258
Suchorska, B., Weller, M., Tabatabai, G., Senft, C., Hau, P., Sabel, M. C., Herrlinger, U., Ketter, R., Schlegel, U., Marosi, C., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov326 · Cited by 254
Huang, R., Harmsen, S., Samii, J. M., Karabeber, H., Pitter, K. L., Holland, E. C., & Kircher, M. F. (2016) · Theranostics · doi:10.7150/thno.13842 · Cited by 111
Eatz, T. A., Eichberg, D. G., Lu, V. M., Di, L., Komotar, R. J., & Ivan, M. E. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03901-9 · Cited by 93
Chaichana, K. L., Pinheiro, L., & Brem, H. (2015) · Therapeutic Delivery · doi:10.4155/tde.14.114 · Cited by 91
Resection of gliomas deemed inoperable by neurosurgeons based on preoperative imaging studies
Southwell, D. G., Birk, H. S., Han, S. J., Li, J., Sall, J. W., & Berger, M. S. (2018) · Journal of Neurosurgery · doi:10.3171/2017.5.jns17166 · Cited by 71
Self-citationBlack, D., Kaneko, S., Walke, A., König, S., Stummer, W., & Suero Molina, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-99228-6 · Cited by 46
Izadyyazdanabadi, M., Belykh, E., Mooney, M. A., Eschbacher, J. M., Nakaji, P., Yang, Y., & Preul, M. C. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00240 · Cited by 45
Suero Molina, E., Black, D., Kaneko, S., Müther, M., & Stummer, W. (2022) · Journal of Neurosurgery · doi:10.3171/2021.12.jns211724 · Cited by 28
Strickland, B. A., Wedemeyer, M., Ruzevick, J., Micko, A., Shahrestani, S., Daneshmand, S., Shiroishi, M. S., Hwang, D. H., Attenello, F., Chen, T., et al. (2022) · Journal of Neurosurgery · doi:10.3171/2022.1.jns212562 · Cited by 15
Metadata
- Authors
- Sanai, N., Polley, M.-Y., McDermott, M. W., Parsa, A. T., & Berger, M. S.
- Venue
- Journal of Neurosurgery
- Published
- 2011-07
- Volume
- 115
- Issue
- 1
- Pages
- 3-8
- ISSN
- 0022-3085 (ISSN-L)
- 1933-0693
- OpenAlex
- W1887747927
- Cited by
- 1,646
- References
- 12
- FWCI
- 32.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.